Home › Stocks › AVNS › All Fund Holders
AVNS — AVANOS MED INC · All Fund Holders
Funds holding (latest): 46 · Reported value held: $540.08M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 7.47M | $185.82M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 3.53M | $39.61M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 1.52M | $37.93M | 0.01% | Add |
| Geode Capital Management history | Q2 2026 | 1.18M | $29.39M | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 1.10M | $27.42M | 0.00% | New |
| Charles Schwab Investment Management history | Q2 2026 | 946.34K | $23.55M | 0.00% | Reduce |
| Fidelity International (FIL) history | Q2 2026 | 815.00K | $20.28M | 0.01% | New |
| Goldman Sachs Group history | Q2 2026 | 765.42K | $19.04M | 0.00% | Add |
| Balyasny Asset Management history | Q2 2026 | 739.83K | $18.41M | 0.02% | New |
| Northern Trust Corp history | Q2 2026 | 523.07K | $13.01M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 472.64K | $11.76M | 0.00% | Reduce |
| Wellington Management Group history | Q1 2023 | 320.85K | $9.54M | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 377.49K | $9.39M | 0.00% | Reduce |
| Marshall Wace history | Q2 2026 | 354.23K | $8.81M | 0.01% | New |
| BNY Mellon history | Q2 2026 | 309.23K | $7.69M | 0.00% | Add |
| Principal Global Investors history | Q2 2026 | 292.10K | $7.27M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 280.73K | $6.98M | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 279.38K | $6.95M | 0.00% | Add |
| Citadel Advisors history | Q1 2026 | 489.70K | $6.86M | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 256.10K | $6.37M | 0.01% | New |
| Invesco Ltd history | Q2 2026 | 203.81K | $5.07M | 0.00% | Reduce |
| Bank of America Corp history | Q2 2026 | 185.96K | $4.63M | 0.00% | Add |
| PSP Investments history | Q2 2026 | 160.87K | $4.00M | 0.01% | Reduce |
| Lazard Asset Management history | Q1 2026 | 282.64K | $3.96M | 0.01% | Add |
| Point72 Asset Management history | Q2 2023 | 134.80K | $3.45M | 0.01% | Reduce |
| AQR Capital Management history | Q2 2026 | 111.56K | $2.78M | 0.00% | Reduce |
| Legal & General Investment Management America history | Q2 2026 | 105.76K | $2.63M | 0.00% | Reduce |
| Citigroup Inc history | Q2 2026 | 80.19K | $2.00M | 0.00% | Add |
| MFS Investment Management history | Q2 2023 | 68.33K | $1.75M | 0.00% | Reduce |
| Norges Bank Investment Management history | Q4 2024 | 104.50K | $1.66M | 0.00% | Reduce |
| Franklin Resources history | Q2 2026 | 64.90K | $1.61M | 0.00% | Reduce |
| Royce & Associates history | Q2 2026 | 60.70K | $1.51M | 0.01% | Reduce |
| Moore Capital Management history | Q1 2026 | 97.96K | $1.37M | 0.03% | Reduce |
| Prudential Financial history | Q2 2026 | 50.34K | $1.25M | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 48.37K | $1.20M | 0.00% | Reduce |
| Two Sigma Investments history | Q2 2026 | 48.29K | $1.20M | 0.00% | Reduce |
| Wells Fargo & Co history | Q2 2026 | 41.19K | $1.02M | 0.00% | Add |
| Arrowstreet Capital history | Q2 2026 | 32.47K | $807.93K | 0.00% | Add |
| CPP Investments history | Q2 2026 | 22.90K | $569.75K | 0.00% | Reduce |
| Maverick Capital history | Q1 2024 | 16.90K | $336.44K | 0.01% | Add |
| Manulife Financial history | Q2 2026 | 11.96K | $297.59K | 0.00% | Reduce |
| Janus Henderson Group history | Q1 2026 | 20.71K | $290.11K | 0.00% | Hold |
| Amundi US history | Q1 2025 | 18.16K | $254.76K | 0.00% | Reduce |
| Bridgewater Associates history | Q3 2024 | 10.47K | $251.62K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2026 | 3.15K | $78.50K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 84.94K | $2.11K | 0.00% | Add |